Osaic Holdings’s Fidelity Disruptive Medicine ETF FMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.69K Hold
114
– – ﹤0.01% 7115
2026
Q2
$3.25K Buy
+114
New +$2.89K ﹤0.01% 7110

Other funds holding FMED

Osaic Holdings's FMED Position: Q3 2026 in Review

Osaic Holdings held its Fidelity Disruptive Medicine ETF (FMED) position steady in Q3 2026 at 114 shares worth $3.69K. The position accounts for ﹤0.01% of the portfolio, ranked #7115.

Osaic Holdings first reported a position in FMED in Q2 2026 and has held it in 2 quarters since. 14 funds tracked by Wall St. Rank hold FMED as of Q3 2026.

  • Osaic Holdings held 114 shares of Fidelity Disruptive Medicine ETF worth $3.69K as of Q3 2026.
  • Osaic Holdings left its Fidelity Disruptive Medicine ETF share count unchanged in Q3 2026.
  • Fidelity Disruptive Medicine ETF made up ﹤0.01% of Osaic Holdings's portfolio in Q3 2026, its #7115 holding.
  • Osaic Holdings first reported a position in Fidelity Disruptive Medicine ETF in Q2 2026 and has held it in 2 quarters since.
  • 14 funds tracked by Wall St. Rank held Fidelity Disruptive Medicine ETF as of Q3 2026.

Based on Osaic Holdings's 13F filing for Q3 2026, filed 12 Nov 2026.